Mathilde Bohin News Today

THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISTRIBUTED OR TRANSMITTED, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR IN ANY OTHER...

BORDEAUX, France & BOSTON, December 12, 2023--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME plans), a medical technology company specializing in implants for orthopedic surgery and the distribution of technological medical equipment, announces the launch of its surgeon training program with a view to marketing its JAZZ® range in China.

Press release Minutes of Implanets Annual General Meeting held on May 3, 2023 Bordeaux,... | May 4, 2023

33% gross margin improvement to €5 million 15% operating loss reduction 23% improvement in the net result Sanyou Medical increases its stake in Implanet to 43.14% via the exercise

Record unit sales of JAZZsolutions (+31%) Export sales momentum recorded in the first 3 quarters of 2022 Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for

Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: GeNeuro (Paris:GNRO): Market: Euronext Paris ISIN code Mnemo: CH0308403085 GNRO Web

SMTP Technology Co., a Sanyou Medical subsidiary, is a Chinese company specialized in manufacturing and marketing ultrasonic medical equipment Exclusive distribution agreement covering healthcare

Revenue increase driven by business in France and the rest of the world, which grew by 40% and 73% respectively Third consecutive quarter of revenue growth Success of the proposed capital

Regulatory News: GeNeuro (Euronext Paris: CH0308403085 GNRO), a biopharmaceutical company focused on stopping causal factors driving the progression of neurodegenerative and autoimmune diseases such

First fundraising of €2.77 million through the issuance of 9,879,254 shares with warrants Acquisition of a 28.96% stake in Sanyou (HK) International Medical Holding Co. limited ("Sanyou Medical")